Reata Pharmaceuticals, Inc. Receives Orphan Drug Designation for Omaveloxolone for the Treatment of Malignant Melanoma

World News: . []

IRVING Texas Sept 13 2017 GLOBE NEWSWIRE -- Reata Pharmaceuticals Inc NasdaqRETA Reata or the Company”), a clinical-stage biopharmaceutical company today announced that the United States Food and Drug Administration FDA ”) ha...

More news and information about Reata Pharmaceuticals, Inc.

Published By:

Globe Newswire: 22:26 GMT Wednesday 13th September 2017

Published: .

Search for other references to "reata" on SPi News

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us

Advertising on SPi News: Information For Advertisers